Gaur 2021.

Study characteristics
Notes	English title Macrolevel association of COVID‐19 with non‐communicable disease risk factors in India Study setting Start of study recruitment (MM/YYYY) 02/2020 End of study recruitment (MM/YYYY) 11/2020 Study design registry data Study centre(s) multiple centres/clinics/areas within a country Number of centres/clinics/areas unspecified Study setting unspecified Number of participants recruited unspecified Sampling method other Participants Female participants (unspecified) Age measure, value not reported Inclusion criteria unspecified Exclusion criteria unspecified Smoking NR Diabetes (unspecified), the frequency of diabetes was reported for each province of India separately.  Hypertension (unspecified), the frequency of HTN was reported for each province of India separately.  Cardiovascular diseases (unspecified) Please indicate if additional information is available  NR Asthma (unspecified) Chronic obstructive pulmonary disease (unspecified) Other pulmonary diseases (unspecified) Please indicate if additional information is available  NR Immunosuppression (unspecified) Please indicate if additional information is available NR Chronic kidney disease (unspecified) Cancer (unspecified) Steroid administration (unspecified) Supplemental oxygen (unspecified) Differential values for various oxygenation methods (if indicated) NR Other treatment NR Dose if applicable NR Duration if applicable NR Percentage received this treatment NR Prognostic factor(s) Study’s definition for obesity unspecified The time when obesity has been measured unspecified Main variable used for determination of obesity other (please specify) Threshold used for definition of obesity  unspecified Measure of frequency unspecified Frequency value the frequency of obesity was reported for each province of India separately.  How many eligible outcomes reported? 1 How many eligible outcomes reported? 1 Outcome(s) mortality Outcome (prognostic factor) mortality (obesity not specified) Outcome mortality Prognostic factor (category):  Obesity not specified Follow‐up Number of patients followed completely for this outcome  unspecified Number of obese patients followed completely for this outcome  unspecified Number of non‐obese patients followed completely for this outcome  unspecified Univariable (unadjusted) analysis for obesity Effect measure for obesity slope (beta) Effect measure value (95% CI) 0.52 NR Multivariable (adjusted) analysis for obesity Modelling method other (please specify) The set of prognostic factors used for adjustment obesity, HTN, diabetes, literacy, smoking Effect measure for obesity slope (beta) Effect measure value (95% CI) ‐0.13 (unspecified, unspecified)
Item	Authors' judgement	Support for judgement
Study Participation	No	Appendix 3
Study Attrition Mortality	Yes	Appendix 3
Prognostic Factor Measurement	No	Appendix 3
Outcome Measurement Mortality	No	Appendix 3
Confounding Bias Mortality	No	Appendix 3
Statistical Analysis Bias	No	Appendix 3